摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 | 586410-08-4

中文名称
顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯
中文别名
顺式3,4',5-三甲氧基-3'-羟基二苯乙烯;顺式3,4',5 - 三甲氧基-3' - 羟基二苯乙烯
英文名称
cis-3,4',5-trimethoxy-3'-hydroxystilbene
英文别名
5-[(Z)-2-(3,5-dimethoxyphenyl)ethenyl]-2-methoxyphenol
顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯化学式
CAS
586410-08-4
化学式
C17H18O4
mdl
——
分子量
286.328
InChiKey
UQIWTPQGJCCTPA-PLNGDYQASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    N /A
  • 沸点:
    472.8±45.0 °C(Predicted)
  • 密度:
    1.177±0.06 g/cm3(Predicted)
  • 溶解度:
    可溶于氯仿(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    47.9
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯三氯氧磷三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 6.25h, 生成
    参考文献:
    名称:
    一种芳氧基磷酸酯单钠盐的制备及应用
    摘要:
    本发明公开了一种芳氧基磷酸酯单钠盐的制备方法及应用,其制备步骤是在有机溶剂中,以取代的酚类化合物为原料,在三氯氧磷及碱存在下,在冰水浴中进行磷酰基化反应和碱化反应,反应完成后加入水,搅拌、萃取、干燥、减压浓缩,得到酚的磷酰基化产物;然后滴加NaOH溶液以析出白色沉淀,然后冷却、抽滤、水洗、丙酮泡洗、干燥,得到芳氧基磷酸酯单钠盐。进一步,采用芳氧基磷酸酯单钠盐制备芳氧基磷酸酯二钠盐、芳氧基磷酸二氢酯及芳氧基磷酸酯盐。本发明具有后处理简洁高效、收率高、适合规模化制备的优点。
    公开号:
    CN106146548B
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers
    摘要:
    New carbon-11 and fluorine-18 labeled stilbene derivatives, cis-3,5-dimethoxy-4'-[C-11]methoxystilbene (4'-[C-11]8a), cis-3,4',5-trimethoxy-3'-[C-11]methoxystilbene (3'-[C-11]8b), trans-3,5-dimethoxy-4'-[C-11]methoxystilbene (4'-[C-11]10a), trans-3,4',5-trirnethoxy-3'-[C-11]methoxystilbene (3'-[C-11]10b), cis- 3,5-dimethoxy-4'-[F-18]fluorostilbene (4'-[F-18]12a), and trans-3,5-dimethoxy-4'-[F-18]fluorostilbene (4'-[F-18]13a), were designed and synthesized as potential PET probes for aryl hydrocarbon receptor (AhR) in cancers. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.08.088
点击查看最新优质反应信息

文献信息

  • STILBENE DERIVATIVES AS NEW CANCER THERAPEUTIC AGENTS
    申请人:Lee Ruey-min
    公开号:US20080261982A1
    公开(公告)日:2008-10-23
    Stilbene derivatives exhibit killing and suppression of growth activity against a variety of cancer cells, and are effective at suppressing tumor growth in vivo. The stilbene derivatives may be used in the treatment of diseases characterized by cell hyperproliferation including human malignancies and non-malignant diseases such as liver cirrhosis. Stilbenes may also disrupt abnormal vessels in tumor to achieve vascular disrupting effect to suppress tumor growth. Water soluble pro-drug forms of stilbene derivatives are particularly useful in suppressing tumor growth in vivo.
    Stilbene衍生物表现出对多种癌细胞的杀灭和抑制生长活性,并且在体内有效地抑制肿瘤生长。Stilbene衍生物可用于治疗以细胞过度增殖为特征的疾病,包括人类恶性肿瘤和非恶性疾病,如肝硬化。Stilbenes也可以破坏肿瘤中的异常血管,实现血管破坏效应以抑制肿瘤生长。水溶性的Stilbene衍生物前药形式在体内抑制肿瘤生长方面特别有用。
  • CuI/1,10-phen/PEG promoted decarboxylation of 2,3-diarylacrylic acids: synthesis of stilbenes under neutral and microwave conditions with an in situ generated recyclable catalyst
    作者:Yong Zou、Qi Huang、Tong-kun Huang、Qing-chun Ni、En-sheng Zhang、Tian-long Xu、Mu Yuan、Jun Li
    DOI:10.1039/c3ob41588k
    日期:——
    A series of trans- or cis-stilbenes have been synthesized in good to excellent yields via a functional group-dependent decarboxylation process from the corresponding 2,3-diaryl acrylic acids in a neutral CuI/1,10-phen/PEG-400 system under microwave conditions. The in situ generation of the recyclable catalytic complex, the use of environmentally benign solvent PEG-400, the operational simplicity, the short reaction times, as well as the functional group-dependent chemo- and stereo-selectivity have made the decarboxylation process a highly efficient and applicable protocol.
    在中性 CuI/1,10-phen/PEG-400 体系中,通过官能团依赖性脱羧过程,从相应的 2,3-二芳基丙烯酸中合成了一系列反式或顺式二苯乙烯,收率良好至优异在微波条件下。可回收催化复合物的原位生成、环境友好溶剂 PEG-400 的使用、操作简单、反应时间短以及官能团依赖性化学和立体选择性使得脱羧过程成为高度高效且适用的协议。
  • Methods and compositions for treatment of cancer and autoimmune disease
    申请人:THE JACKSON LABORATORY
    公开号:US10207988B2
    公开(公告)日:2019-02-19
    The technology described herein relates to methods of inducing cell death. The technology described herein further relates to treating conditions including cancers and autoimmune diseases comprising administering inhibitors of double strand break repair. Also described herein are inhibitors of double strand break repair and methods of screening for such inhibitors.
    本文所述技术涉及诱导细胞死亡的方法。本文所述技术还涉及通过施用双链断裂修复抑制剂来治疗包括癌症和自身免疫性疾病在内的疾病。本文还描述了双链断裂修复抑制剂和筛选此类抑制剂的方法。
  • Compositions and methods for immune-mediated cancer therapy
    申请人:Teclison Limited
    公开号:US11534445B2
    公开(公告)日:2022-12-27
    Disclosed herein are methods and compositions for enhancing an immune response to a solid tumor in a subject. In some embodiments, a method comprises: (a) administering to the subject a hypoxia-activated bioreductive agent (HABA); (b) inducing hypoxia by (i) administering a hypoxia-inducing agent to the subject or (ii) embolizing one or more blood vessels supplying the solid tumor; and (c) administering an immune checkpoint inhibitor prior to, simultaneously with, or subsequent to step (b) in an amount effective to enhance an immune response to the solid tumor, as compared to an immune response in the absence of the immune checkpoint inhibitor. Kits for use in the disclosed methods are also provided.
    本文公开了用于增强受试者对实体瘤的免疫应答的方法和组合物。在一些实施方案中,方法包括(a) 向受试者施用缺氧激活的生物还原剂(HABA);(b) 通过(i)向受试者施用缺氧诱导剂或(ii)栓塞供应实体瘤的一个或多个血管来诱导缺氧;以及(c)在步骤(b)之前、同时或之后施用免疫检查点抑制剂,施用量有效于增强对实体瘤的免疫应答,与不施用免疫检查点抑制剂时的免疫应答相比。还提供了用于所公开方法的试剂盒。
  • Design, synthesis and biological evaluation of novel stilbene-based antitumor agents
    作者:Daniele Simoni、Francesco Paolo Invidiata、Marco Eleopra、Paolo Marchetti、Riccardo Rondanin、Riccardo Baruchello、Giuseppina Grisolia、Ashutosh Tripathi、Glen E. Kellogg、David Durrant、Ray M. Lee
    DOI:10.1016/j.bmc.2008.12.002
    日期:2009.1
    A series of novel stilbene derivatives has been synthesized and studied with the main goal to investigate SAR of the amino compound 1a, as well as to improve its water solubility, a potentially negative aspect of the molecule that could be a serious obstacle for a pre-clinical development. We have obtained derivatives with good cytotoxic activity, in particular, the derivatives 5c and 6b could represent two novel leads for further investigation. Compound 8b, a morpholino-carbamate derivative, prodrug of 1a, has a very good solubility in water, and is active in suppressing growth of tumor cells at a concentration of 5000 nM, which is a concentration 100 times higher than the parent stilbene 1a. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸